Cargando…
The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis
Although antimicrobial therapy is recommended for patients with moderate or severe ischemic colitis, its beneficial effects are unclear. In the present study, the role of antimicrobial therapy in the treatment of ischemic colitis was investigated. Patients with ischemic colitis were retrospectively...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408655/ https://www.ncbi.nlm.nih.gov/pubmed/32664298 http://dx.doi.org/10.3390/jcm9072182 |
_version_ | 1783567881455271936 |
---|---|
author | Lee, Jae Gon Park, Jin Hwa Han, Dong Soo Lee, Hang Lak Park, Chan Hyuk Eun, Chang Soo |
author_facet | Lee, Jae Gon Park, Jin Hwa Han, Dong Soo Lee, Hang Lak Park, Chan Hyuk Eun, Chang Soo |
author_sort | Lee, Jae Gon |
collection | PubMed |
description | Although antimicrobial therapy is recommended for patients with moderate or severe ischemic colitis, its beneficial effects are unclear. In the present study, the role of antimicrobial therapy in the treatment of ischemic colitis was investigated. Patients with ischemic colitis were retrospectively identified between January 2004 and June 2019. The characteristics and outcomes of patients who received antibiotics (antibiotics group) and those who did not (no-antibiotics group) were compared. Clinical outcomes included death, surgery, and readmission within 30 days, fasting duration, and hospital stay. Data from 186 patients were analyzed; 122 patients were in the antibiotics group and 64 in the no-antibiotics group. Composite outcome of death, surgery, and readmission within 30 days occurred in 3.3% of patients in the antibiotics group and 3.1% of patients in the no-antibiotics group (p > 0.999). Fasting duration was not significantly different between the two groups (median days, 4.0 vs. 4.0, p = 0.253). However, hospital stays were longer in the antibiotics group than in the no-antibiotics group (median days, 9.0 vs. 7.0, p = 0.043). In patients with ischemic colitis, there was no statistically significant difference in the incidence of death, surgery, and readmission within 30 days between patients who received antibiotics and those who did not receive antibiotics. |
format | Online Article Text |
id | pubmed-7408655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74086552020-08-13 The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis Lee, Jae Gon Park, Jin Hwa Han, Dong Soo Lee, Hang Lak Park, Chan Hyuk Eun, Chang Soo J Clin Med Article Although antimicrobial therapy is recommended for patients with moderate or severe ischemic colitis, its beneficial effects are unclear. In the present study, the role of antimicrobial therapy in the treatment of ischemic colitis was investigated. Patients with ischemic colitis were retrospectively identified between January 2004 and June 2019. The characteristics and outcomes of patients who received antibiotics (antibiotics group) and those who did not (no-antibiotics group) were compared. Clinical outcomes included death, surgery, and readmission within 30 days, fasting duration, and hospital stay. Data from 186 patients were analyzed; 122 patients were in the antibiotics group and 64 in the no-antibiotics group. Composite outcome of death, surgery, and readmission within 30 days occurred in 3.3% of patients in the antibiotics group and 3.1% of patients in the no-antibiotics group (p > 0.999). Fasting duration was not significantly different between the two groups (median days, 4.0 vs. 4.0, p = 0.253). However, hospital stays were longer in the antibiotics group than in the no-antibiotics group (median days, 9.0 vs. 7.0, p = 0.043). In patients with ischemic colitis, there was no statistically significant difference in the incidence of death, surgery, and readmission within 30 days between patients who received antibiotics and those who did not receive antibiotics. MDPI 2020-07-10 /pmc/articles/PMC7408655/ /pubmed/32664298 http://dx.doi.org/10.3390/jcm9072182 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Jae Gon Park, Jin Hwa Han, Dong Soo Lee, Hang Lak Park, Chan Hyuk Eun, Chang Soo The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis |
title | The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis |
title_full | The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis |
title_fullStr | The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis |
title_full_unstemmed | The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis |
title_short | The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis |
title_sort | uncertain effect of antimicrobial therapy in the treatment of patients with ischemic colitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408655/ https://www.ncbi.nlm.nih.gov/pubmed/32664298 http://dx.doi.org/10.3390/jcm9072182 |
work_keys_str_mv | AT leejaegon theuncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT parkjinhwa theuncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT handongsoo theuncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT leehanglak theuncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT parkchanhyuk theuncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT eunchangsoo theuncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT leejaegon uncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT parkjinhwa uncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT handongsoo uncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT leehanglak uncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT parkchanhyuk uncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis AT eunchangsoo uncertaineffectofantimicrobialtherapyinthetreatmentofpatientswithischemiccolitis |